Medical Automation Market: Strong Pipeline to Rapidly Surge Growth

The Medical Automation Market is gaining traction, with a 5.2% CAGR over the forecast period (2022-2032). Automated patient monitoring systems are gaining traction in the healthcare sector, which is expected to boost the market's growth rate.

Automation technology is the use of control systems and software to independently operate and monitor a mechanised system. These automated systems are used in a variety of industrial processes such as chemicals and materials, food and beverage, healthcare, and others. Automated delivery of medical practises reduces human errors, saves money in the long run, and streamlines the process with better results.

The growing use of point-of-care testing devices such as HIV test kits, pregnancy test kits, and digital blood pressure monitors is expected to drive the growth of the medical automation market.

Key Takeaways

  • The rising demand for accuracy and dependability in medical procedures, as well as increased government investment, are some of the key factors driving the medical automation market. Another factor driving high sales in the medical automation market is rising labour costs.
  • The medical automation market is divided into several segments based on application, geography, and end-users. The application segment is further subdivided into therapeutic automation market, medical automation market, and lab & pharmacy automation market.
  • The medical automation market is further subdivided into automated image analysis, automated imaging, and point of care testing. The automated imaging market is divided into four major segments: automated radiography, automated microscopy, capsule endoscopy, and automated fluoroscopy.
  • The lab and pharmacy automation markets can be divided into two categories: lab automation and pharmacy automation. Microplate readers, liquid handling, automated storage and retrieval systems, stand-alone robots, and software and informatics systems are all part of the lab automation market.
  • The pharmacy automation market includes automated medication dispensing systems, automated packaging and labelling systems, and automated medication compounding systems.
  • In the medical automation market, end users are further classified as pharmacies, research laboratories and institutes, hospitals and diagnostic centres, home/ambulatory care, and others. However, strict government regulations for medical device manufacturers around the world are likely to stymie the market's growth.

Competitive Landscape

iAccuray, Inc., Beckman Coulter, Inc., Asahi Kasei Corp, Carefusion Corp, GE Healthcare, Lifescan, Inc., Medtronic, Inc., Intuitive Surgical Inc., Omnicell, Inc, Roche Holding AG, Philips Healthcare, Siemens Healthcare, St. Jude Medical, Inc., Stanley Black and Decker, Inc, Swisslog Holdings AG, Stryker Corporation, Simsurgery As, Parata Systems LLC are some of the key companies profiled in the full version of the report.

Browse More@ https://www.futuremarketinsights.com/reports/medical-automation-market

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more